1 | hour | 4,152 |
2 | minute | 2,434 |
3 | milligram | 63 |
4 | millisecond | 35 |
5 | mile | 31 |
6 | integron | 30 |
7 | half-hour | 27 |
8 | metre | 24 |
9 | nanogram | 16 |
10 | hour/day | 13 |
11 | serving/day | 12 |
12 | centimetre | 11 |
13 | ounce | 11 |
14 | time/day | 11 |
15 | gev/u | 10 |
16 | second/forced | 10 |
17 | kilometre | 9 |
18 | drink/day | 8 |
19 | time/week | 8 |
20 | copy/ml | 7 |
21 | micromole | 7 |
22 | s/forced | 7 |
23 | 12hours | 6 |
24 | 5mo | 6 |
25 | 3.5h | 5 |
26 | millimole | 5 |
27 | serving/wk | 5 |
28 | dioptre | 4 |
29 | nhai | 4 |
30 | repetition-maximum | 4 |
31 | tablespoon | 4 |
32 | microgram/min | 3 |
33 | serving/week | 3 |
34 | unit/day | 3 |
35 | µm-head | 3 |
36 | 1-ml/min | 2 |
37 | 10-microg/m | 2 |
38 | crise | 2 |
39 | european-australasian | 2 |
40 | g/dl-hb | 2 |
41 | microg.microl | 2 |
42 | microm-1 | 2 |
43 | non-urea | 2 |
44 | person-day | 2 |
45 | pill/day | 2 |
46 | planigale | 2 |
47 | pr/4 | 2 |
48 | submetacentric | 2 |
49 | teaspoonful | 2 |
50 | vkgm | 2 |
51 | volt | 2 |
52 | 0.1-g/dl | 1 |
53 | 0/0.064 | 1 |
54 | 1,2,3-propanetriol | 1 |
55 | 1/2-h | 1 |
56 | 1/2-hour | 1 |
57 | 10.3g | 1 |
58 | 10.5-mm | 1 |
59 | 1000-m | 1 |
60 | 124.43 | 1 |
61 | 13,82 | 1 |
62 | 198.34 | 1 |
63 | 2-amino-5-benzyl-3-eth-oxy-carbonyl-4,5,6,7-tetra-hydro-thieno | 1 |
64 | 2.7*10 | 1 |
65 | 210.01 | 1 |
66 | 250μm | 1 |
67 | 2:59h | 1 |
68 | 3'-azido-3'-de-oxy-thymidine-5'amino-carbonyl-phospho-nate | 1 |
69 | 337.84 | 1 |
70 | 4,6-dimethoxy-5-methyl-2h-pyran-2-one | 1 |
71 | 4-amino-5-fluoro-2-oxo-2,3-di-hydro-pyrimidin-1-ium | 1 |
72 | 533.8 | 1 |
73 | 631g | 1 |
74 | 862±439 | 1 |
75 | algopareunia | 1 |
76 | american/indian | 1 |
77 | analyses-a | 1 |
78 | and25 | 1 |
79 | applicatorful | 1 |
80 | broth-salmonella | 1 |
81 | c-h∙∙∙n | 1 |
82 | ca-dinucleotide-repeat | 1 |
83 | cal/cm² | 1 |
84 | cleidotomy | 1 |
85 | client/clinic | 1 |
86 | cui3 | 1 |
87 | cup/month | 1 |
88 | cycle=artificial | 1 |
89 | datapoint | 1 |
90 | day-with | 1 |
91 | degree-of-freedrom | 1 |
92 | df=1·64 | 1 |
93 | dose-limiting-toxicity | 1 |
94 | douche/day | 1 |
95 | folk-healer | 1 |
96 | g/6h | 1 |
97 | g/dog | 1 |
98 | glyco-protein | 1 |
99 | half-tablet | 1 |
100 | hawfinch | 1 |
101 | hbsβ | 1 |
102 | hour-educational | 1 |
103 | hour׳s | 1 |
104 | imf-screw | 1 |
105 | insert-deletion | 1 |
106 | kj/week | 1 |
107 | km/1/2 | 1 |
108 | kpa·l | 1 |
109 | legem | 1 |
110 | light-initiated | 1 |
111 | light-sensor | 1 |
112 | m/2 | 1 |
113 | macro-sequencing | 1 |
114 | mae=33 | 1 |
115 | matsiguenga | 1 |
116 | mb=100 | 1 |
117 | member-month | 1 |
118 | mg/kg.h | 1 |
119 | microg/kg/minute | 1 |
120 | microgl | 1 |
121 | microm-30 | 1 |
122 | midsymphyseal | 1 |
123 | minute/forced | 1 |
124 | ml/10-cm | 1 |
125 | mm-3.5 | 1 |
126 | mm×1 | 1 |
127 | ms-brief | 1 |
128 | munit | 1 |
129 | nap-sleep | 1 |
130 | nct00252720 | 1 |
131 | nct00252733 | 1 |
132 | neutro® | 1 |
133 | optimally-weighted | 1 |
134 | oral-formulation | 1 |
135 | orus | 1 |
136 | p-then-x | 1 |
137 | post-scopolamine | 1 |
138 | pseudo-hypoaldosteronism | 1 |
139 | qald | 1 |
140 | rbc/high | 1 |
141 | sept-1st | 1 |
142 | session/d | 1 |
143 | sif6 | 1 |
144 | sth-peak | 1 |
145 | strigiform | 1 |
146 | subgroup-with | 1 |
147 | sulforaphane-rich | 1 |
148 | symptom-day | 1 |
149 | tablet/h | 1 |
150 | time-ssht | 1 |
151 | trial/year | 1 |
152 | vaccinia-psa | 1 |
153 | ventromedian | 1 |
154 | void/night | 1 |
155 | vs.11 | 1 |
156 | year-to | 1 |
157 | year-was | 1 |
158 | year=3.0±0.7 | 1 |
159 | year=3.2±0.8 | 1 |
160 | ×k | 1 |
1 | 0.1-g/dl | 1 |
2 | 0/0.064 | 1 |
3 | 1,2,3-propanetriol | 1 |
4 | 1-ml/min | 2 |
5 | 1/2-h | 1 |
6 | 1/2-hour | 1 |
7 | 10-microg/m | 2 |
8 | 10.3g | 1 |
9 | 10.5-mm | 1 |
10 | 1000-m | 1 |
11 | 124.43 | 1 |
12 | 12hours | 6 |
13 | 13,82 | 1 |
14 | 198.34 | 1 |
15 | 2-amino-5-benzyl-3-eth-oxy-carbonyl-4,5,6,7-tetra-hydro-thieno | 1 |
16 | 2.7*10 | 1 |
17 | 210.01 | 1 |
18 | 250μm | 1 |
19 | 2:59h | 1 |
20 | 3'-azido-3'-de-oxy-thymidine-5'amino-carbonyl-phospho-nate | 1 |
21 | 3.5h | 5 |
22 | 337.84 | 1 |
23 | 4,6-dimethoxy-5-methyl-2h-pyran-2-one | 1 |
24 | 4-amino-5-fluoro-2-oxo-2,3-di-hydro-pyrimidin-1-ium | 1 |
25 | 533.8 | 1 |
26 | 5mo | 6 |
27 | 631g | 1 |
28 | 862±439 | 1 |
29 | algopareunia | 1 |
30 | american/indian | 1 |
31 | analyses-a | 1 |
32 | and25 | 1 |
33 | applicatorful | 1 |
34 | broth-salmonella | 1 |
35 | c-h∙∙∙n | 1 |
36 | ca-dinucleotide-repeat | 1 |
37 | cal/cm² | 1 |
38 | centimetre | 11 |
39 | cleidotomy | 1 |
40 | client/clinic | 1 |
41 | copy/ml | 7 |
42 | crise | 2 |
43 | cui3 | 1 |
44 | cup/month | 1 |
45 | cycle=artificial | 1 |
46 | datapoint | 1 |
47 | day-with | 1 |
48 | degree-of-freedrom | 1 |
49 | df=1·64 | 1 |
50 | dioptre | 4 |
51 | dose-limiting-toxicity | 1 |
52 | douche/day | 1 |
53 | drink/day | 8 |
54 | european-australasian | 2 |
55 | folk-healer | 1 |
56 | g/6h | 1 |
57 | g/dl-hb | 2 |
58 | g/dog | 1 |
59 | gev/u | 10 |
60 | glyco-protein | 1 |
61 | half-hour | 27 |
62 | half-tablet | 1 |
63 | hawfinch | 1 |
64 | hbsβ | 1 |
65 | hour | 4,152 |
66 | hour-educational | 1 |
67 | hour/day | 13 |
68 | hour׳s | 1 |
69 | imf-screw | 1 |
70 | insert-deletion | 1 |
71 | integron | 30 |
72 | kilometre | 9 |
73 | kj/week | 1 |
74 | km/1/2 | 1 |
75 | kpa·l | 1 |
76 | legem | 1 |
77 | light-initiated | 1 |
78 | light-sensor | 1 |
79 | m/2 | 1 |
80 | macro-sequencing | 1 |
81 | mae=33 | 1 |
82 | matsiguenga | 1 |
83 | mb=100 | 1 |
84 | member-month | 1 |
85 | metre | 24 |
86 | mg/kg.h | 1 |
87 | microg.microl | 2 |
88 | microg/kg/minute | 1 |
89 | microgl | 1 |
90 | microgram/min | 3 |
91 | microm-1 | 2 |
92 | microm-30 | 1 |
93 | micromole | 7 |
94 | midsymphyseal | 1 |
95 | mile | 31 |
96 | milligram | 63 |
97 | millimole | 5 |
98 | millisecond | 35 |
99 | minute | 2,434 |
100 | minute/forced | 1 |
101 | ml/10-cm | 1 |
102 | mm-3.5 | 1 |
103 | mm×1 | 1 |
104 | ms-brief | 1 |
105 | munit | 1 |
106 | nanogram | 16 |
107 | nap-sleep | 1 |
108 | nct00252720 | 1 |
109 | nct00252733 | 1 |
110 | neutro® | 1 |
111 | nhai | 4 |
112 | non-urea | 2 |
113 | optimally-weighted | 1 |
114 | oral-formulation | 1 |
115 | orus | 1 |
116 | ounce | 11 |
117 | p-then-x | 1 |
118 | person-day | 2 |
119 | pill/day | 2 |
120 | planigale | 2 |
121 | post-scopolamine | 1 |
122 | pr/4 | 2 |
123 | pseudo-hypoaldosteronism | 1 |
124 | qald | 1 |
125 | rbc/high | 1 |
126 | repetition-maximum | 4 |
127 | s/forced | 7 |
128 | second/forced | 10 |
129 | sept-1st | 1 |
130 | serving/day | 12 |
131 | serving/week | 3 |
132 | serving/wk | 5 |
133 | session/d | 1 |
134 | sif6 | 1 |
135 | sth-peak | 1 |
136 | strigiform | 1 |
137 | subgroup-with | 1 |
138 | submetacentric | 2 |
139 | sulforaphane-rich | 1 |
140 | symptom-day | 1 |
141 | tablespoon | 4 |
142 | tablet/h | 1 |
143 | teaspoonful | 2 |
144 | time-ssht | 1 |
145 | time/day | 11 |
146 | time/week | 8 |
147 | trial/year | 1 |
148 | unit/day | 3 |
149 | vaccinia-psa | 1 |
150 | ventromedian | 1 |
151 | vkgm | 2 |
152 | void/night | 1 |
153 | volt | 2 |
154 | vs.11 | 1 |
155 | year-to | 1 |
156 | year-was | 1 |
157 | year=3.0±0.7 | 1 |
158 | year=3.2±0.8 | 1 |
159 | µm-head | 3 |
160 | ×k | 1 |
1 | mb=100 | 1 |
2 | 2.7*10 | 1 |
3 | nct00252720 | 1 |
4 | microm-30 | 1 |
5 | microm-1 | 2 |
6 | 210.01 | 1 |
7 | vs.11 | 1 |
8 | mm×1 | 1 |
9 | km/1/2 | 1 |
10 | m/2 | 1 |
11 | 13,82 | 1 |
12 | nct00252733 | 1 |
13 | mae=33 | 1 |
14 | 124.43 | 1 |
15 | cui3 | 1 |
16 | pr/4 | 2 |
17 | 198.34 | 1 |
18 | 0/0.064 | 1 |
19 | df=1·64 | 1 |
20 | 337.84 | 1 |
21 | mm-3.5 | 1 |
22 | and25 | 1 |
23 | sif6 | 1 |
24 | year=3.0±0.7 | 1 |
25 | year=3.2±0.8 | 1 |
26 | 533.8 | 1 |
27 | 862±439 | 1 |
28 | analyses-a | 1 |
29 | non-urea | 2 |
30 | matsiguenga | 1 |
31 | algopareunia | 1 |
32 | broth-salmonella | 1 |
33 | vaccinia-psa | 1 |
34 | g/dl-hb | 2 |
35 | client/clinic | 1 |
36 | submetacentric | 2 |
37 | session/d | 1 |
38 | µm-head | 3 |
39 | second/forced | 10 |
40 | minute/forced | 1 |
41 | s/forced | 7 |
42 | light-initiated | 1 |
43 | optimally-weighted | 1 |
44 | qald | 1 |
45 | millisecond | 35 |
46 | ounce | 11 |
47 | planigale | 2 |
48 | mile | 31 |
49 | millimole | 5 |
50 | micromole | 7 |
51 | post-scopolamine | 1 |
52 | 4,6-dimethoxy-5-methyl-2h-pyran-2-one | 1 |
53 | metre | 24 |
54 | centimetre | 11 |
55 | kilometre | 9 |
56 | dioptre | 4 |
57 | crise | 2 |
58 | 3'-azido-3'-de-oxy-thymidine-5'amino-carbonyl-phospho-nate | 1 |
59 | minute | 2,434 |
60 | microg/kg/minute | 1 |
61 | ms-brief | 1 |
62 | 631g | 1 |
63 | 10.3g | 1 |
64 | macro-sequencing | 1 |
65 | g/dog | 1 |
66 | 1/2-h | 1 |
67 | mg/kg.h | 1 |
68 | tablet/h | 1 |
69 | 3.5h | 5 |
70 | g/6h | 1 |
71 | 2:59h | 1 |
72 | sulforaphane-rich | 1 |
73 | hawfinch | 1 |
74 | rbc/high | 1 |
75 | subgroup-with | 1 |
76 | day-with | 1 |
77 | member-month | 1 |
78 | cup/month | 1 |
79 | nhai | 4 |
80 | sth-peak | 1 |
81 | time/week | 8 |
82 | serving/week | 3 |
83 | kj/week | 1 |
84 | serving/wk | 5 |
85 | ×k | 1 |
86 | midsymphyseal | 1 |
87 | cycle=artificial | 1 |
88 | hour-educational | 1 |
89 | 0.1-g/dl | 1 |
90 | microgl | 1 |
91 | copy/ml | 7 |
92 | 1,2,3-propanetriol | 1 |
93 | microg.microl | 2 |
94 | teaspoonful | 2 |
95 | applicatorful | 1 |
96 | kpa·l | 1 |
97 | 1000-m | 1 |
98 | 10-microg/m | 2 |
99 | milligram | 63 |
100 | nanogram | 16 |
101 | ml/10-cm | 1 |
102 | legem | 1 |
103 | vkgm | 2 |
104 | 10.5-mm | 1 |
105 | degree-of-freedrom | 1 |
106 | strigiform | 1 |
107 | pseudo-hypoaldosteronism | 1 |
108 | 4-amino-5-fluoro-2-oxo-2,3-di-hydro-pyrimidin-1-ium | 1 |
109 | repetition-maximum | 4 |
110 | 250μm | 1 |
111 | ventromedian | 1 |
112 | american/indian | 1 |
113 | european-australasian | 2 |
114 | glyco-protein | 1 |
115 | 1-ml/min | 2 |
116 | microgram/min | 3 |
117 | oral-formulation | 1 |
118 | insert-deletion | 1 |
119 | tablespoon | 4 |
120 | integron | 30 |
121 | c-h∙∙∙n | 1 |
122 | 5mo | 6 |
123 | 2-amino-5-benzyl-3-eth-oxy-carbonyl-4,5,6,7-tetra-hydro-thieno | 1 |
124 | year-to | 1 |
125 | nap-sleep | 1 |
126 | trial/year | 1 |
127 | folk-healer | 1 |
128 | light-sensor | 1 |
129 | hour | 4,152 |
130 | 1/2-hour | 1 |
131 | half-hour | 27 |
132 | year-was | 1 |
133 | 12hours | 6 |
134 | orus | 1 |
135 | hour׳s | 1 |
136 | ca-dinucleotide-repeat | 1 |
137 | half-tablet | 1 |
138 | void/night | 1 |
139 | time-ssht | 1 |
140 | munit | 1 |
141 | volt | 2 |
142 | datapoint | 1 |
143 | sept-1st | 1 |
144 | gev/u | 10 |
145 | imf-screw | 1 |
146 | p-then-x | 1 |
147 | symptom-day | 1 |
148 | person-day | 2 |
149 | douche/day | 1 |
150 | time/day | 11 |
151 | serving/day | 12 |
152 | drink/day | 8 |
153 | pill/day | 2 |
154 | hour/day | 13 |
155 | unit/day | 3 |
156 | cleidotomy | 1 |
157 | dose-limiting-toxicity | 1 |
158 | neutro® | 1 |
159 | cal/cm² | 1 |
160 | hbsβ | 1 |